227 related articles for article (PubMed ID: 9686516)
1. Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes.
Hast R; Eriksson M; Jakovleva K
Pol Arch Med Wewn; 1998 Feb; 99(2):144-9. PubMed ID: 9686516
[No Abstract] [Full Text] [Related]
2. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Hoelzer D
Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
[No Abstract] [Full Text] [Related]
3. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
Greenberg PL
Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
[No Abstract] [Full Text] [Related]
4. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
Ganser A; Hoelzer D
Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic growth factor therapy of myelodysplastic syndromes.
Arcenas AG; Vadhan-Raj S
Leuk Lymphoma; 1993; 11 Suppl 2():65-9. PubMed ID: 7510197
[No Abstract] [Full Text] [Related]
6. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
[No Abstract] [Full Text] [Related]
7. [Clinical use of hematopoietic growth factors].
Robak T
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
[No Abstract] [Full Text] [Related]
8. Treatment of myelodysplastic syndromes with cytokines and cytotoxic drugs.
Ganser A; Seipelt G; Eder M; Geissler G; Ottmann OG; Hess U; Hoelzer D
Semin Oncol; 1992 Apr; 19(2 Suppl 4):95-101. PubMed ID: 1372766
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study.
Bernell P; Kimby E; Hast R
Leukemia; 1994 Oct; 8(10):1631-9. PubMed ID: 7934158
[TBL] [Abstract][Full Text] [Related]
10. A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.
Croockewit AJ; Bronchud MH; Aapro MS; Bargetzi MJ; Crown J; Gratwohl A; Lange W; Ludwig H; Martinelli G; Mertelsmann R; Nuessler V; Willemze R; De Witte TJ; Zittoun R; Zwierzina H
Eur J Cancer; 1997 Oct; 33(11):1732-46. PubMed ID: 9470826
[No Abstract] [Full Text] [Related]
11. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
St Onge J; Jacobson RJ
Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
[No Abstract] [Full Text] [Related]
12. Hematopoietic growth factors in the treatment of the myelodysplastic syndromes.
Ganser A
Curr Opin Hematol; 1995 May; 2(3):204-9. PubMed ID: 9371996
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Karthaus M
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():13-27. PubMed ID: 9570676
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
Hast R; Bernell P
Acta Haematol Pol; 1991; 22(2):203-7. PubMed ID: 1726768
[No Abstract] [Full Text] [Related]
15. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
16. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
17. The role of bone marrow transplantation in the treatment of myelodysplastic syndromes.
Schultz AB; Geller RB; Hillyer CD
J Hematother; 1995 Aug; 4(4):323-34. PubMed ID: 7489147
[No Abstract] [Full Text] [Related]
18. Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high-grade lymphoma.
Laporte JP; Lesage S; Woler M; Parlier Y; Daguenel A; Najman A; Gorin NC
Eur J Haematol; 1994 Aug; 53(2):123-5. PubMed ID: 7522189
[No Abstract] [Full Text] [Related]
19. [Current and future use of hemopoietic growth factors].
Reguart N; Gascón P
Med Clin (Barc); 2001 Mar; 116(10):390-4. PubMed ID: 11333675
[No Abstract] [Full Text] [Related]
20. Priming with granulocyte colony-stimulating factor--relation to high-dose cytarabine in acute myeloid leukemia.
Büchner T; Berdel WE; Hiddemann W
N Engl J Med; 2004 May; 350(21):2215-6. PubMed ID: 15152074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
